Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

TBPH

Theravance Biopharma Inc

May 29 • 04:00PM ET

16.06

-0.15 -0.93 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: HRMY SUPN ALKS PRGO BHC AMRX INDV LNTH TEVA VTRS

| Held by: VTI IWM VXF PBE IBB XPH CALF IWO JSMD VTWO

Scroll to Statements

Index	RUT	P/E	7.28	EPS (ttm)	2.20	Insider Own	6.40%	Shs Outstand	51.52M	Perf Week	-1.71%
Market Cap	827.94M	Forward P/E	11.82	EPS next Y	1.36	Insider Trans	-1.85%	Shs Float	48.25M	Perf Month	-3.66%
Enterprise Value	506.57M	PEG	-	EPS next Q	0.06	Inst Own	96.96%	Short Float	10.35%	Perf Quarter	-12.00%
Income	114.54M	P/S	7.54	EPS this Y	21.93%	Inst Trans	-0.73%	Short Ratio	8.64	Perf Half Y	-15.21%
Sales	109.78M	P/B	2.85	EPS next Y	-45.92%	ROA	28.08%	Short Interest	4.99M	Perf YTD	-14.16%
Book/sh	5.64	P/C	2.10	EPS next 5Y	-26.08%	ROE	50.17%	52W High	21.03 -23.63%	Perf Year	72.69%
Cash/sh	7.66	P/FCF	3.08	EPS past 3/5Y	- -	ROIC	32.43%	52W Low	9.10 76.48%	Perf 3Y	45.21%
Dividend Est.	-	EV/EBITDA	87.49	Sales past 3/5Y	27.91% 8.38%	Gross Margin	94.81%	Volatility	1.86% 2.18%	Perf 5Y	-7.06%
Dividend TTM	-	EV/Sales	4.61	EPS Y/Y TTM	291.20%	Oper. Margin	0.08%	ATR (14)	0.38	Perf 10Y	-29.41%
Dividend Ex-Date	-	Quick Ratio	13.14	Sales Y/Y TTM	68.20%	Profit Margin	104.34%	RSI (14)	40.88	Recom	1.80
Dividend Gr. 3/5Y	- -	Current Ratio	13.14	EPS Q/Q	64.79%	SMA20	-2.82%	Beta	0.17	Target Price	17.40
Payout	0.00%	Debt/Eq	0.25	Sales Q/Q	15.02%	SMA50	-1.23%	Rel Volume	0.92	Prev Close	16.21
Employees	90	LT Debt/Eq	0.22	Earnings	May 07 BMO	SMA200	-2.35%	Avg Volume	578.04K	Price	16.06
IPO	May 16, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	-457.14% -0.47%	Trades		Volume	531,017	Change	-0.93%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)